Elanco Animal Health Incorporated (ELAN) Stock Grade

About Elanco Animal Health Incorporated's fundamentals

Elanco Animal Health is a $11.8 billion specialty pharmaceutical company serving the animal health market with revenue growth of 6.2% year-over-year. The company reported a net loss in its latest annual statement, reflecting a negative net margin of -4.9%, though it generated positive free cash flow despite these accounting losses. Without a current P/E ratio due to its unprofitable status and no dividend yield, the company's financial position shows growth in sales alongside near-term profitability challenges.